Close Menu
Invest Insider News
    Facebook X (Twitter) Instagram
    Friday, May 1
    Facebook X (Twitter) Instagram Pinterest Vimeo
    Invest Insider News
    • Home
    • Bitcoin
    • Commodities
    • Finance
    • Investing
    • Property
    • Stock Market
    • Utilities
    Invest Insider News
    Home»Stock Market»Buy or sell: Sumeet Bagadia recommends these three stocks to buy on Monday — July 22
    Stock Market

    Buy or sell: Sumeet Bagadia recommends these three stocks to buy on Monday — July 22

    July 21, 20244 Mins Read


    Buy or sell stocks: Following weak global market trends on rising US-China tension, the Indian stock market ended lower on Friday. The Nifty 50 index corrected 269 points and closed at 24,530, while the BSE Sensex lost 738 points and ended at 80,604. The Bank Nifty index nosedived 355 points and finished at 52,265. Tech outages down 8.8 percent hindered cash market volumes on the NSE. The broad market indices fell more than the Nifty 50 index even as the advance-decline ratio fell to 0.18:1, the lowest in 1.5 months.

    Sumeet Bagadia’s stock recommendations

    Sumeet Bagadia, Executive Director at Choice Broking, believes that the Nifty 50 index has formed a bearish candle after sharp selling at the 24,850 level. The Choice Broking expert said that crucial support for the 50-stock index has now shifted to the 24,200 mark. Bagadia said that the Indian stock market sentiment would turn weak once the Nifty breaches below this crucial support of 24,200.

    Get Quick Cash in Minutes!

    Best Personal Loan at Lowest Interest Rates

    Instant Apply

    Regarding stocks to buy on Monday, Sumeet Bagadia recommended buying these three buy or sell stocks: Glenmark Pharmaceuticals, Colgate Palmolive, and Asian Paints.



    Sumeet Bagadia’s stocks to buy next week

    1] Glenmark Pharmaceuticals: Buy at ₹1412.95, target ₹1525, stop loss ₹1350.

    Glenmark Pharmaceuticals share price currently trades at ₹1412.95, showcasing a solid upward trend. The stock’s position above all major moving averages highlights its strength and potential for further gains. The minor resistance at ₹1425, an all-time high, is a critical level to watch. If GLENMARK sustains a breakthrough above this resistance, it could accelerate towards the target price of ₹1525 and beyond. The robust volume and price movement suggest investor confidence and potential upside momentum.

    We recommend buying Glenmark Pharmaceuticals shares at the current market price of ₹1412.95, leveraging the positive trend observed in the charts. The short—to medium-term target is set at ₹1525, contingent on the stock maintaining its upward trajectory. This recommendation is backed by strong technical indicators and market sentiment favouring continued growth.

    However, our analysis and buy recommendation will be invalidated if the stock closes below ₹1350, as this would indicate a potential reversal or significant correction. Investors should maintain this level to stop loss and manage risk effectively.

    2] Colgate Palmolive or COLPAL: Buy at ₹3120.95, target ₹3370, stop loss ₹2980.

    The COLPAL share price has exhibited a noteworthy rebound from the support level of ₹2980, which is also close to its 20-day EMA levels, currently trading at approximately ₹3120.95. The stock’s positioning above its 20-day, 50-day, and 200-day Exponential Moving Averages (EMA) signals a positive trend, reflecting strength in its current trajectory. The momentum indicator, Relative Strength Index (RSI), comfortably rising to 74.83 levels, underscores the stock’s robust performance.

    A minor resistance is observed at ₹3150 levels. A successful breach of this level could propel COLPAL share towards the target of ₹3370 and beyond, suggesting further potential upside.

    Investors and traders may find this technical analysis valuable for assessing COLPAL’s current strength and potential future movements. However, it’s essential to consider broader market conditions and conduct thorough research before making investment decisions.

    Based on the above analysis, we expect COLPAL to move higher towards ₹3370. Hence, we recommend buying COLPAL at a CMP of ₹3120.95 with an SL of ₹2980.

    3] Asian Paints: Buy at ₹2946, target ₹3190, stop loss ₹2840.

    Asian Paints share is currently trading at ₹2946.05 levels, above both the 20-day and 50-day EMA, indicating strength in the short term. A more minor resistance is placed at 3030 levels, representing a recent high. Once the stock sustains above this level, it has the potential to move further towards the ₹3190 level.

    Additionally, the Bollinger Bands on the daily chart are squeezed, suggesting a potential for increased volatility. After testing the lower band, the price remains above the middle line of the Bollinger Band, indicating the stock’s strength and potential for an upward move, breaking through the higher band.

    Furthermore, the RSI indicator comfortably trades near 52.40 levels, indicating that the stock may continue to rise. This RSI level suggests that the stock is neither overbought nor oversold, providing room for upward movement. Overall, the technical indicators point to a positive outlook for the stock, with the potential for further gains if it surpasses the ₹3030 resistance level.

    With a medium-term target price of 3190, we advise purchasing Asian Paints shares at the CMP of ₹2946.05. It can also be accumulated close to ₹2900 levels. Our analysis will be considered invalid if the price closes below ₹2840.



    Disclaimer: The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.


    Topics You May Be Interested In



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous Article2 Phenomenal Stocks to Buy on the Dip
    Next Article Ether ETFs Are Coming. Wall Street Is Split on Their Impact

    Related Posts

    Stock Market

    Stock Market Today (LIVE): Atlassian Soars 20% on Cloud Strength; Age Checks Throttle Roblox’s Growth

    May 1, 2026
    Stock Market

    MAB lists on LSE’s Main Market

    May 1, 2026
    Stock Market

    “Important milestone” as Mortgage Advice Bureau moves to Main Market

    May 1, 2026
    Leave A Reply Cancel Reply

    Top Posts

    How is the UK Commercial Property Market Performing?

    December 31, 2000

    How much are they in different states across the US?

    December 31, 2000

    A Guide To Becoming A Property Developer

    December 31, 2000
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews
    Finance

    5 Lessons Parents Should Teach Teens About Money, According to ‘Rich Dad’ Robert Kiyosaki

    August 24, 2024
    Stock Market

    U.S. stocks soar to their best day since May as the Dow tops 50,000 – NBC New York

    February 6, 2026
    Investing

    Sodexo shares slump 16% as H1 profit halves, outlook cut By Investing.com

    April 10, 2026
    What's Hot

    NBFC stock plummets 7% after mixed Q2 results — Buy, sell or hold?

    November 10, 2025

    investing for kids: The True Cost of Education: Why you can’t afford not investing for your kids

    August 26, 2024

    Titan Wealth acquires £750m AUA Finance Shop and FS Wealth Management

    July 30, 2025
    Most Popular

    BTC $66,000 support remains strong

    October 28, 2024

    Bitcoin Near $67,000 Amid Market Volatility

    March 30, 2026

    Voici comment protéger votre portefeuille

    March 20, 2025
    Editor's Picks

    Repligen executive sells over $1.1 million in company stock By Investing.com

    August 6, 2024

    Wall Street dégringole de près de 6% à la clôture

    April 4, 2025

    voici leur stratégie pour le T3

    June 30, 2025
    Facebook X (Twitter) Instagram Pinterest Vimeo
    • Get In Touch
    • Privacy Policy
    • Terms and Conditions
    © 2026 Invest Insider News

    Type above and press Enter to search. Press Esc to cancel.